Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis-Reference-Cited by-同舟云学术

Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis

Published:2018-03-24 Issue:6 Volume:283 Page:568-577
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Adler B. L.¹,Pezhouh M. K.²,Kim A.³,Luan L.²,Zhu Q.²,Gani F.⁴,Yarchoan M.⁵,Chen J.⁶,Voltaggio L.²,Parian A.³,Lazarev M.³,Lauwers G. Y.⁶,Pawlik T. M.⁷,Montgomery E. A.²,Jaffee E.⁵⁸,Le D. T.⁵,Taube J. M.²⁸,Anders R. A.²⁸

Affiliation:

1. Department of Rheumatology; Johns Hopkins University School of Medicine; Baltimore MD USA

2. Department of Pathology; Johns Hopkins University School of Medicine; Baltimore MD USA

3. Department of Gastroenterology; Johns Hopkins University School of Medicine; Baltimore MD USA

4. Department of Surgery; Johns Hopkins University School of Medicine; Baltimore MD USA

5. Department of Medical Oncology; Johns Hopkins University School of Medicine; Baltimore MD USA

6. Department of Pathology; H. Lee Moffitt Cancer and Research Institute; Tampa FL USA

7. Department of Surgery; Ohio State University Wexner Medical Center; Columbus OH USA

8. The Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins; Baltimore MD USA

Funder

The NCI SPORE in Gastrointestinal Cancers

The Johns Hopkins Bloomberg-Kimmel Institute for Cancer Immunotherapy

The Viragh Foundation

National Institutes of Health

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12744/fullpdf

Reference33 articles.

1. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat Rev Cancer,2012

2. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4;Takahashi;J Exp Med,2000

3. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy;Chambers;Annu Rev Immunol,2001

4. Blockade of CTLA-4 on CD4 + CD25 + regulatory T cells abrogates their function in vivo;Read;J Immunol,2006

5. Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells;Selby;Cancer Immunol Res,2013

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enterocolitis y otras manifestaciones de toxicidad gastrointestinal asociada a inmunoterapia y terapia blanco: una revisión para el gastroenterólogo;Revista de Gastroenterología de México;2024-01

2. Enterocolitis and other immunotherapy and targeted therapy-related gastrointestinal manifestations: A review for gastroenterologist;Revista de Gastroenterología de México (English Edition);2024-01

3. Histopathologic Features of Unmasked Inflammatory Bowel Disease Following Immune Checkpoint Inhibitor Therapy in Colon Biopsies;Gastro Hep Advances;2024

4. Histopathologic Manifestations of Immune Checkpoint Inhibitor Therapy-Associated Gastrointestinal Tract Injury;Surgical Pathology Clinics;2023-12

5. Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach;Inflammatory Bowel Diseases;2023-10-06